With unblinding as soon as this week the run-up should start tomorrow morning taking CYDY to at least $7 by Friday, but I wouldn't be surprised to see $10 then sell off to $7
The risk to the success of CYDY is not Nader, the risk is a crooked FDA not giving any type of approval to LL for any indication. IF we do not get EUA or flat out approval for covid, no need to worry about any money in the coffers for other trials, because at that point LL will never get approval for anything until it is owned by a BP.